168 related articles for article (PubMed ID: 26662569)
1. The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer.
Li J; Ye Y; Wang M; Lu L; Han C; Zhou Y; Zhang J; Yu Z; Zhang X; Zhao C; Wen J; Kan Q
Tumour Biol; 2016 May; 37(5):6881-91. PubMed ID: 26662569
[TBL] [Abstract][Full Text] [Related]
2. Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer.
Ye Y; Jiang D; Li J; Wang M; Han C; Zhang X; Zhao C; Wen J; Kan Q
Tumour Biol; 2016 Mar; 37(3):3185-95. PubMed ID: 26432329
[TBL] [Abstract][Full Text] [Related]
3. Combination of the FGFR4 inhibitor PD173074 and 5-fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
Ye YW; Hu S; Shi YQ; Zhang XF; Zhou Y; Zhao CL; Wang GJ; Wen JG; Zong H
Oncol Rep; 2013 Dec; 30(6):2777-84. PubMed ID: 24126887
[TBL] [Abstract][Full Text] [Related]
4. [Difference of gene expression profile in human gastric cancer grafted onto nude mice treated with WCA].
Zhao AG; Yang JK; You SF; Li T; Zhao HL; Gu Y; Tang LD
Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2028-36. PubMed ID: 18161298
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
[TBL] [Abstract][Full Text] [Related]
6. Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
Jiang D; Li J; Li J; Wang M; Han C; Wang X; Zhao C; Ye Y
Int J Oncol; 2017 Nov; 51(5):1611-1620. PubMed ID: 29048661
[TBL] [Abstract][Full Text] [Related]
7. [Effect of combination of docosahexaenoic acid and fluorouracil on human gastric carcinoma cell strain MGC803].
Wu Q; Yu JC; Liu YQ; Kang WM; Guo WD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Feb; 32(1):65-70. PubMed ID: 20236591
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
9. [Effects of traditional Tibetan drug Liu Tea on proliferation and chemotherapeutic sensitivity of drug-resistant human gastric cancer cell BGC823/5-FU].
Cheng Y; Hasiqi MG; Qin XZ; Tang XY; Chen JN; Wang HY; Gao A
Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):603-608. PubMed ID: 28871679
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer.
Turkington RC; Longley DB; Allen WL; Stevenson L; McLaughlin K; Dunne PD; Blayney JK; Salto-Tellez M; Van Schaeybroeck S; Johnston PG
Cell Death Dis; 2014 Feb; 5(2):e1046. PubMed ID: 24503538
[TBL] [Abstract][Full Text] [Related]
11. Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.
Liu Y; Bi T; Dai W; Wang G; Qian L; Shen G; Gao Q
Naunyn Schmiedebergs Arch Pharmacol; 2016 May; 389(5):477-84. PubMed ID: 26892272
[TBL] [Abstract][Full Text] [Related]
12. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
13. Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.
Ezzat S; Zheng L; Winer D; Asa SL
Mol Endocrinol; 2006 Nov; 20(11):2965-75. PubMed ID: 16857743
[TBL] [Abstract][Full Text] [Related]
14. BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro.
Zhang X; Zhang X; Han R; Wang Z; Yang Q; Huang Y; Yan Y
Biochem Biophys Res Commun; 2022 Mar; 595():22-27. PubMed ID: 35093636
[TBL] [Abstract][Full Text] [Related]
15. Jianpi Yangwei decoction promotes apoptosis and suppresses proliferation of 5-fluorouracil resistant gastric cancer cells in vitro and in vivo.
Tang H; Huang W; Yang Q; Lin Y; Chen Y; Shu P
BMC Complement Med Ther; 2020 Nov; 20(1):337. PubMed ID: 33167958
[TBL] [Abstract][Full Text] [Related]
16. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth.
Ezzat S; Huang P; Dackiw A; Asa SL
Clin Cancer Res; 2005 Feb; 11(3):1336-41. PubMed ID: 15709206
[TBL] [Abstract][Full Text] [Related]
18. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.
Wang J; Hu W; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2016 Apr; 48(4):1341-52. PubMed ID: 26847910
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
Kim HM; Kim SA; Park SB; Cho JH; Song SY
Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
[TBL] [Abstract][Full Text] [Related]
20. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil.
Chen WY; Huang CY; Cheng WL; Hung CS; Huang MT; Tai CJ; Liu YN; Chen CL; Chang YJ
Tumour Biol; 2015 Dec; 36(12):9537-44. PubMed ID: 26136123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
